124 related articles for article (PubMed ID: 15603882)
1. A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues.
Li D; Brackenridge S; Screaton GR
Hum Immunol; 2004 Dec; 65(12):1539-45. PubMed ID: 15603882
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of CD45 isoforms is controlled by the combined activity of basal and inducible splicing-regulatory elements in each of the variable exons.
Tong A; Nguyen J; Lynch KW
J Biol Chem; 2005 Nov; 280(46):38297-304. PubMed ID: 16172127
[TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities.
Pulido R; Schlossman SF; Saito H; Streuli M
J Exp Med; 1994 Mar; 179(3):1035-40. PubMed ID: 7509359
[TBL] [Abstract][Full Text] [Related]
4. Different types of in vivo induced cytolytic T lymphocytes are all LFA-Ihigh and lack CD45 exon 4 (CD45RA) but show distinct CD45RC profiles.
Hansson J; Ericsson PO; Widegren B; Dohlsten M; Sjögren HO; Hedlund G
Int Immunol; 1994 Sep; 6(9):1375-81. PubMed ID: 7819146
[TBL] [Abstract][Full Text] [Related]
5. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors.
ten Dam GB; Zilch CF; Wallace D; Wieringa B; Beverley PC; Poels LG; Screaton GR
J Immunol; 2000 May; 164(10):5287-95. PubMed ID: 10799890
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD45 isoforms lacking exons 7, 8 and 10.
Virts E; Barritt D; Raschke WC
Mol Immunol; 1998 Feb; 35(3):167-76. PubMed ID: 9694517
[TBL] [Abstract][Full Text] [Related]
7. Organization and expression of thirteen alternatively spliced exons in catfish CD45 homologs.
Kountikov E; Wilson M; Miller N; Clem W; Bengtén E
Dev Comp Immunol; 2004 Aug; 28(10):1023-35. PubMed ID: 15236932
[TBL] [Abstract][Full Text] [Related]
8. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans.
Zilch CF; Walker AM; Timón M; Goff LK; Wallace DL; Beverley PC
Eur J Immunol; 1998 Jan; 28(1):22-9. PubMed ID: 9485182
[TBL] [Abstract][Full Text] [Related]
9. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
Lemaire R; Winne A; Sarkissian M; Lafyatis R
Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
[TBL] [Abstract][Full Text] [Related]
10. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors.
Rothstein DM; Saito H; Streuli M; Schlossman SF; Morimoto C
J Biol Chem; 1992 Apr; 267(10):7139-47. PubMed ID: 1532394
[TBL] [Abstract][Full Text] [Related]
11. HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing.
Preussner M; Schreiner S; Hung LH; Porstner M; Jäck HM; Benes V; Rätsch G; Bindereif A
Nucleic Acids Res; 2012 Jul; 40(12):5666-78. PubMed ID: 22402488
[TBL] [Abstract][Full Text] [Related]
12. A novel alternative spliced chondrolectin isoform lacking the transmembrane domain is expressed during T cell maturation.
Weng L; Van Bockstaele DR; Wauters J; Van Marck E; Plum J; Berneman ZN; Merregaert J
J Biol Chem; 2003 May; 278(21):19164-70. PubMed ID: 12621022
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of CD45 pre-mRNA is uniquely obedient to conditions in lymphoid cells.
ten Dam GB; Wieringa B; Poels LG
Biochim Biophys Acta; 1999 Sep; 1446(3):317-33. PubMed ID: 10524206
[TBL] [Abstract][Full Text] [Related]
14. CD45 alternative exon expression in murine and human CD4+ T cell subsets.
Rogers PR; Pilapil S; Hayakawa K; Romain PL; Parker DC
J Immunol; 1992 Jun; 148(12):4054-65. PubMed ID: 1351092
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing, expression, and genomic structure of the 3' region of the gene encoding the sarcolemmal-associated proteins (SLAPs) defines a novel class of coiled-coil tail-anchored membrane proteins.
Wielowieyski PA; Sevinc S; Guzzo R; Salih M; Wigle JT; Tuana BS
J Biol Chem; 2000 Dec; 275(49):38474-81. PubMed ID: 10986292
[TBL] [Abstract][Full Text] [Related]
16. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression.
Barnier JV; Papin C; Eychène A; Lecoq O; Calothy G
J Biol Chem; 1995 Oct; 270(40):23381-9. PubMed ID: 7559496
[TBL] [Abstract][Full Text] [Related]
17. Novel alternatively spliced isoforms of the neurofibromatosis type 2 tumor suppressor are targeted to the nucleus and cytoplasmic granules.
Schmucker B; Tang Y; Kressel M
Hum Mol Genet; 1999 Aug; 8(8):1561-70. PubMed ID: 10401006
[TBL] [Abstract][Full Text] [Related]
18. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing.
Hovanes K; Li TW; Waterman ML
Nucleic Acids Res; 2000 May; 28(9):1994-2003. PubMed ID: 10756202
[TBL] [Abstract][Full Text] [Related]
19. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
Terry A; Kilbey A; Vaillant F; Stewart M; Jenkins A; Cameron E; Neil JC
Gene; 2004 Jul; 336(1):115-25. PubMed ID: 15225881
[TBL] [Abstract][Full Text] [Related]
20. The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans.
Tchilian EZ; Wallace DL; Imami N; Liao HX; Burton C; Gotch F; Martinson J; Haynes BF; Beverley PC
J Immunol; 2001 May; 166(10):6144-8. PubMed ID: 11342634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
